US Stock MarketDetailed Quotes

BME Blackrock Health Sciences Trust

Watchlist

40.455
+0.165+0.41%

Trading May 21 11:22 ET

564.10MMarket Cap28.09P/E (TTM)

Blackrock Health Sciences Trust Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q2)Jun 30, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q2)Jun 30, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q2)Jun 30, 2021

(FY)Dec 31, 2020

Assets

Cash cash equivalents and federal funds sold

-82.87%534

-99.91%606

224.79%3.12K

15.33%675.17K

-99.55%960

--960

13,413.99%585.43K

69.08%211.7K

-Cash and cash equivalents

-82.87%534

-99.15%606

224.79%3.12K

-77.63%71.67K

-99.55%960

--960

7,296.72%320.43K

181.49%211.7K

-Restricted cash and investments

--0

127.74%603.5K

--0

--265K

--0

Receivables

-31.81%1.62M

171.61%3.99M

-25.47%2.37M

2.95%1.47M

188.28%3.18M

--3.18M

45.23%1.43M

27.62%1.1M

Prepaid assets

--5.29K

----

--0

----

-14.85%4.78K

-Available for sale securities

31.53%31.4M

----

--23.87M

----

Derivative assets

-88.40%275

--0

--2.37K

----

Deferred costs

5.66%82.6K

-24.22%76.54K

-14.56%78.17K

-2.08%101K

-27.84%91.5K

--91.5K

-26.35%103.14K

-15.24%126.81K

Total assets

-1.65%596.1M

25.77%607.78M

-6.58%606.13M

-21.40%483.25M

17.00%648.81M

--648.81M

28.37%614.83M

22.32%554.55M

Liabilities

Payables

-30.34%621.39K

159.28%1.71M

-93.23%892.03K

-67.48%658.77K

2,137.02%13.17M

--13.17M

371.34%2.03M

-20.70%588.72K

-Accounts payable

----

459,093.91%528.07K

-98.13%233.2K

-99.96%115

10,828.50%12.48M

--12.48M

--317.51K

--114.21K

-Other payable

-5.68%621.39K

79.15%1.18M

-4.27%658.83K

-61.44%658.66K

45.04%688.25K

--688.25K

297.46%1.71M

-36.08%474.51K

Long term debt and capital lease obligation

1,978.29%60.69K

79.47%96.19K

--2.92K

464.63%53.6K

----

--9.49K

----

Derivative product liabilities

68.22%7.27M

89.61%6.15M

-55.07%4.32M

-46.09%3.25M

23.54%9.62M

--9.62M

-12.90%6.02M

41.63%7.79M

Other liabilities

----

379.69%2.54M

219.46%675.9K

22.75%529.38K

106.01%211.57K

--211.57K

3,900.50%431.25K

-59.53%102.7K

Total liabilities

34.31%7.97M

128.70%10.53M

-74.25%5.93M

-47.04%4.61M

167.38%23.04M

--23.04M

14.55%8.7M

30.90%8.62M

Shareholders'equity

Share capital

-1.57%417.62M

8.97%427.83M

8.65%424.3M

4.94%392.61M

15.16%390.51M

--390.51M

17.09%374.12M

16.07%339.11M

-common stock

-1.57%417.62M

8.97%427.83M

8.65%424.3M

4.94%392.61M

15.16%390.51M

--390.51M

17.09%374.12M

16.07%339.11M

Retained earnings

-3.06%170.52M

96.91%169.42M

-25.24%175.9M

-62.92%86.04M

13.75%235.27M

--235.27M

52.79%232.02M

33.76%206.83M

Total stockholders'equity

-2.01%588.14M

24.78%597.25M

-4.09%600.2M

-21.03%478.64M

14.62%625.77M

--625.77M

28.59%606.13M

22.20%545.94M

Total equity

-2.01%588.14M

24.78%597.25M

-4.09%600.2M

-21.03%478.64M

14.62%625.77M

--625.77M

28.59%606.13M

22.20%545.94M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q2)Jun 30, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q2)Jun 30, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q2)Jun 30, 2021	(FY)Dec 31, 2020
Assets
Cash cash equivalents and federal funds sold	-82.87%534	-82.87%534	-99.91%606	224.79%3.12K	224.79%3.12K	15.33%675.17K	-99.55%960	--960	13,413.99%585.43K	69.08%211.7K
-Cash and cash equivalents	-82.87%534	-82.87%534	-99.15%606	224.79%3.12K	224.79%3.12K	-77.63%71.67K	-99.55%960	--960	7,296.72%320.43K	181.49%211.7K
-Restricted cash and investments	--0	--0	--0	--0	--0	127.74%603.5K	--0	--0	--265K	--0
Receivables	-31.81%1.62M	-31.81%1.62M	171.61%3.99M	-25.47%2.37M	-25.47%2.37M	2.95%1.47M	188.28%3.18M	--3.18M	45.23%1.43M	27.62%1.1M
Prepaid assets	--5.29K	--5.29K	----	----	----	--0	--0	--0	----	-14.85%4.78K
-Available for sale securities	31.53%31.4M	31.53%31.4M	----	--23.87M	--23.87M	----	----	----	----	----
Derivative assets	-88.40%275	-88.40%275	--0	--2.37K	--2.37K	----	----	----	----	----
Deferred costs	5.66%82.6K	5.66%82.6K	-24.22%76.54K	-14.56%78.17K	-14.56%78.17K	-2.08%101K	-27.84%91.5K	--91.5K	-26.35%103.14K	-15.24%126.81K
Total assets	-1.65%596.1M	-1.65%596.1M	25.77%607.78M	-6.58%606.13M	-6.58%606.13M	-21.40%483.25M	17.00%648.81M	--648.81M	28.37%614.83M	22.32%554.55M
Liabilities
Payables	-30.34%621.39K	-30.34%621.39K	159.28%1.71M	-93.23%892.03K	-93.23%892.03K	-67.48%658.77K	2,137.02%13.17M	--13.17M	371.34%2.03M	-20.70%588.72K
-Accounts payable	----	----	459,093.91%528.07K	-98.13%233.2K	-98.13%233.2K	-99.96%115	10,828.50%12.48M	--12.48M	--317.51K	--114.21K
-Other payable	-5.68%621.39K	-5.68%621.39K	79.15%1.18M	-4.27%658.83K	-4.27%658.83K	-61.44%658.66K	45.04%688.25K	--688.25K	297.46%1.71M	-36.08%474.51K
Long term debt and capital lease obligation	1,978.29%60.69K	1,978.29%60.69K	79.47%96.19K	--2.92K	--2.92K	464.63%53.6K	----	----	--9.49K	----
Derivative product liabilities	68.22%7.27M	68.22%7.27M	89.61%6.15M	-55.07%4.32M	-55.07%4.32M	-46.09%3.25M	23.54%9.62M	--9.62M	-12.90%6.02M	41.63%7.79M
Other liabilities	----	----	379.69%2.54M	219.46%675.9K	219.46%675.9K	22.75%529.38K	106.01%211.57K	--211.57K	3,900.50%431.25K	-59.53%102.7K
Total liabilities	34.31%7.97M	34.31%7.97M	128.70%10.53M	-74.25%5.93M	-74.25%5.93M	-47.04%4.61M	167.38%23.04M	--23.04M	14.55%8.7M	30.90%8.62M
Shareholders'equity
Share capital	-1.57%417.62M	-1.57%417.62M	8.97%427.83M	8.65%424.3M	8.65%424.3M	4.94%392.61M	15.16%390.51M	--390.51M	17.09%374.12M	16.07%339.11M
-common stock	-1.57%417.62M	-1.57%417.62M	8.97%427.83M	8.65%424.3M	8.65%424.3M	4.94%392.61M	15.16%390.51M	--390.51M	17.09%374.12M	16.07%339.11M
Retained earnings	-3.06%170.52M	-3.06%170.52M	96.91%169.42M	-25.24%175.9M	-25.24%175.9M	-62.92%86.04M	13.75%235.27M	--235.27M	52.79%232.02M	33.76%206.83M
Total stockholders'equity	-2.01%588.14M	-2.01%588.14M	24.78%597.25M	-4.09%600.2M	-4.09%600.2M	-21.03%478.64M	14.62%625.77M	--625.77M	28.59%606.13M	22.20%545.94M
Total equity	-2.01%588.14M	-2.01%588.14M	24.78%597.25M	-4.09%600.2M	-4.09%600.2M	-21.03%478.64M	14.62%625.77M	--625.77M	28.59%606.13M	22.20%545.94M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	--	--	Unqualified Opinion	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall